RAPID MICRO BIOSYSTEMS, INC.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $33.6M | $28.1M | $22.5M | $17.1M | $23.2M |
| Operating income | -$47.4M | -$49.9M | -$56.6M | -$63.2M | -$47.2M |
| Cash from operations | -$31.1M | -$44.2M | -$45.1M | -$58.5M | -$55.0M |
| Capital expenditure | $850,000 | $1.4M | $1.8M | $6.7M | $3.2M |
| Free cash flow | -$31.9M | -$45.5M | -$46.9M | -$65.3M | -$58.2M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $74.9M | $98.2M | $143.5M | $190.7M | $241.2M |
| Total liabilities | $41.6M | $22.8M | $25.5M | $26.5M | $20.2M |
Shares outstanding 46.2M · Free float 48.7%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.